|

Contrast-Enhanced Spectral Mammography (CESM)

RECRUITINGPhase 2Sponsored by European Institute of Oncology
Actively Recruiting
PhasePhase 2
SponsorEuropean Institute of Oncology
Started2020-11-16
Est. completion2025-02-28
Eligibility
Age18 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06311695

Summary

The study's objective is to compare the diagnostic accuracy of the contrast-enhanced mammography (CEM) , considering as reference the classification obtained with Vacuum Assisted Breast Biopsy (VABB).

Eligibility

Age: 18 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Patients with breast lesions, who underwent bilateral CEM
* Histological assessment

Exclusion Criteria:

* The subject is known to have risks of adverse effects with iodine contrast agents
* The subject has breasts too large to be adequately positioned on Full field digital mammography (FFDM) digital receptor without anatomical cut off during an FFDM examination

Conditions2

Breast CancerCancer

Browse More Trials

Cancer trialsBreast Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.